Literature DB >> 122526

Penicillin and netilmicin in treatment of experimental enterococcal endocarditis.

J Carrizosa, D Kaye.   

Abstract

Successful therapy of enterococcal endocarditis requires the use of a combination of penicillin plus an aminoglycoside. The effectiveness of penicillin (Pen), streptomycin (Str), and netilmicin (Net), a new aminoglycoside, alone and in combination, were studied in vitro and in the treatment of left-sided enterococcal endocarditis in rabbits. In vitro Pen+Str or Net resulted in a more rapid and more complete bactericidal effect than Pen, Str, or Net alone against a Str-susceptible strain of enterococcus (strain 1). Against a highly Str-resistant strain (strain 2), Pen+Net showed an advantage over Pen, Str, or Net alone, or Pen+Str. Endocarditis was produced in rabbits with strain 1 or 2, and treatment was initiated 24 h later. Rabbits were treated for 48 h or 5 days with procaine Pen, Pen+Str, or Pen+Net. With strain 1, numbers of enterococci in the vegetations decreased more rapidly with Pen+Str or Pen+Net treatment than with Pen, Str, or Net alone. With strain 2, Pen+Net showed a clear advantage over Pen, Str, Net, or Pen+Str. Net in combination with Pen showed synergistic in vitro activity and was more effective than Pen alone in the treatment of enterococcal endocarditis in rabbits caused by both Str-susceptible and Str-resistant strains.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 122526      PMCID: PMC352272          DOI: 10.1128/AAC.13.3.505

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Enterococcal endocarditis. Report of nineteen cases with long-term follow-up data.

Authors:  M G KOENIG; D KAYE
Journal:  N Engl J Med       Date:  1961-02-09       Impact factor: 91.245

2.  The antibiotic therapy of bacterial endocarditis: therapeutic data on 172 patients seen from 1951 through 1957: additional observations on short-term therapy (two weeks) for penicillin-sensitivie streptococcal endocarditis.

Authors:  J E GERACI
Journal:  Med Clin North Am       Date:  1958-07       Impact factor: 5.456

3.  Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin.

Authors:  W C ROBBINS; R TOMPSETT
Journal:  Am J Med       Date:  1951-03       Impact factor: 4.965

4.  Synergy of penicillin-netilmicin combinations against enterococci including strains highly resistant to streptomycin or kanamycin.

Authors:  C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

5.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

6.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

8.  Antimicrobial therapy of experimental enterococcal endocarditis.

Authors:  E W Hook; R B Roberts; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

9.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

10.  In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci.

Authors:  H J Harwick; G M Kalmanson; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

View more
  5 in total

1.  Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

2.  Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.

Authors:  P B Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

3.  Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.

Authors:  P M Sullam; M G Täuber; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

Review 4.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

5.  Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.

Authors:  G Perdikaris; H Giamarellou; A Pefanis; I Donta; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.